To access this element change to forms mode OFF
Grant Award View - GA21653
Harnessing the full potential of BH3 mimetics to treat blood cancers
GA ID:
GA21653
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
16-Jul-2018
Publish Date:
12-Sep-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2023
Value (AUD):
$863,923.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Research Fellowship
Grant Activity:
Harnessing the full potential of BH3 mimetics to treat blood cancers
Purpose:
I utilise knowledge gained from basic research to improve healthcare of patients. By exploiting our knowledge of how cell survival is controlled, I led the development of a new anti-cancer drug called venetoclax, now used for chronic lymphocytic leukaemia. I will undertake studies to ascertain how it can be best used in patients with other blood cancers, and begin to develop other similar drugs. My future research seeks to markedly improve treatment for Australian patients with blood cancers.
GO ID:
GO Title:
NHMRC Research Fellowships Scheme
Internal Reference ID:
GNT1156024
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA